🔗 Share this article Social Media Influencers Fueling Unofficial Market for Unlicensed Weight-Loss Medication A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations. Experimental Drug Gaining Traction Online The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to message these profiles privately for source information, while also receiving discount codes. Thriving Trade on Messaging Platforms Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions. Learning About The Experimental Drug Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic. Medical Professionals Express Worries However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in individuals administering substances of unknown origin. Some experts stated the popularity for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro. Legal Status and Enforcement Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012. Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or prison. Platform Response and Content Removal According to the social media company, the service has removed problematic material and prohibited associated keywords and query recommendations. The organization stated it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies. Online Trading Operations Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with photos of slimming results, glowing testimonials and detailed instructions for mixing or injecting at residence. After minutes of entering one group, a seller posted WhatsApp details, where most purchases occur. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage. Item Details and Pricing Inside these groups, messages show dark colored packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”. Service Oversight and Safety Measures A spokesperson for Telegram stated it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”. Healthcare Expert Cautions “Individuals are administering substances they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U. Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said. Her staff has previously encountered patients harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.” Producer Position A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to possibly serious health risks”.